Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells

  • Authors:
    • Naoko Okumura
    • Hitomi Yoshida
    • Yuri Nishimura
    • Yasuko Kitagishi
    • Satoru Matsuda
  • View Affiliations

  • Published online on: November 18, 2011     https://doi.org/10.3892/ol.2011.491
  • Pages: 321-324
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Protein kinase AKT mediates cell proliferation and survival signals, and also contributes to cancer progression. Increased expression and/or activation of AKT is involved in a variety of human cancers. In cells treated with sage or rosemary extract, mRNA and protein expression levels of AKT1 were reduced compared with those of the control cells 48 h after the herbal treatments. We found that terpinolene, a common component of sage and rosemary, markedly reduced the protein expression of AKT1 in K562 cells and inhibited cell proliferation.
View Figures
View References

Related Articles

Journal Cover

February 2012
Volume 3 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Okumura N, Yoshida H, Nishimura Y, Kitagishi Y and Matsuda S: Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells. Oncol Lett 3: 321-324, 2012
APA
Okumura, N., Yoshida, H., Nishimura, Y., Kitagishi, Y., & Matsuda, S. (2012). Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells. Oncology Letters, 3, 321-324. https://doi.org/10.3892/ol.2011.491
MLA
Okumura, N., Yoshida, H., Nishimura, Y., Kitagishi, Y., Matsuda, S."Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells". Oncology Letters 3.2 (2012): 321-324.
Chicago
Okumura, N., Yoshida, H., Nishimura, Y., Kitagishi, Y., Matsuda, S."Terpinolene, a component of herbal sage, downregulates AKT1 expression in K562 cells". Oncology Letters 3, no. 2 (2012): 321-324. https://doi.org/10.3892/ol.2011.491